化学疗法

They say the likely treatment is radiation and kimono ferity chemotherapy .

他们说可能的治疗方式是射线疗法和化学疗法。

Several other poster presentations reinforced the message that once-weekly epoetin was effective, although none of these others had a comparator dose. Two posters presented results from meta-analyses of epoetin alfa clinical trials. One was carried out by Pere Gascon, MD, PhD, and colleagues, from the University of Barcelona, in Spain, and involved 4296 patients with mixed tumor types, while the other, reported by Mario Dicato, MD, from the Luxembourg Medical Center, involved 2019 patients with breast cancer. Both concluded that 40,000-IU epoetin alfa is effective and well tolerated; it ameliorates the impact of chemotherapy on hemoglobin and improves quality of life, thus representing "good anemia management," the researchers concluded.

许多其他的壁报研究同样证实每周投予一次红血球生成素是有效的，虽然其他研究中未使用比较组；另两项比较红血球生成素阿法临床试验结果的综合分析，一项是由Pere Gascon医师与其来自西班牙巴塞隆纳大学的同事，收纳了4，296位各种肿瘤种类病患的研究；另一篇是来自Luxembourg医学中心Mario Dicato医师，收纳2，019位乳癌病患的研究，这两项研究的结论都是40，000单位的红血球生成素阿法同样有效、且耐受性佳；该疗法降低化学疗法对血红素的不良影响，且改善了生活品质，因此可以说为是「良好贫血处理」的标竿。

In this update from the GELA study, 399 patients age 60-80 years with untreated DLCL received eight cycles of standard CHOP every three weeks or eight cycles of R-CHOP (CHOP plus rituximab 375 mg/m2 the same day), and were followed for a median period of 18 months.

他们接受了8个疗程的常规CHOP化学疗法，每3周为一个疗程，或接受了8个疗程的Rituximab-CHOP联合疗法（CHOP疗法，加上同期进行的Rituximab治疗，Rituximab服用剂量为375 mg/m2），治疗后，追踪了大约18个月。

Our data show that the circadian clock and haem biosynthesis are reciprocally regulated and suggest that porphyrin-containing molecules are potential targets for therapy of circadian disorders.

这说明，卟啉衍生物（B12含有卟啉）是如癌症等生物节律失调疾病的潜在治疗药物，而且通过细胞周期调节物质与生物钟之间的联系，还可用在接受化学疗法和放射疗法的患者身上。

Although Dr. Burstein agrees that metronomic chemotherapy alone "did not do all that much," he told Medscape that the combination with bevacizumab is encouraging and that a pilot study is being designed to look at the feasibility of combining bevacizumab with metronomic chemotherapy. The study will compare the combination treatment with bevacizumab alone, but it will not look at metronomic chemotherapy alone.28th Annual SABCS: Abstract 4. Presented Dec.

虽然Burstein医师同意仅接受节律性化学疗法几乎是没有帮助，但他向Medscape表示，结合bevacizumab的合并疗法是有潜力的，而且已经有初期试验检验结合bevacizumab与节律性化学疗法的可行性；这项试验将会比较合并试验与仅接受bevacizumab治疗的反应，但并不会检验仅接受节律性化学疗法的效果。

For Clark Haskins, MD, from New Mexico Oncology Hematology Consultants, Ltd, New Mexico Cancer Center, the data do not support the researchers' positive conclusions."The results were crummy," he told Medscape when asked what he thought of the strategy of using metronomic chemotherapy in advanced disease."The problem is that there are a lot of patients who don't want to take chemotherapy, so this strategy is trying to reach these patients," he said."Unfortunately, the data don't support that the strategy works."

新墨西哥癌症中心新墨西哥肿瘤血液肿瘤谘询家Clark Haskins医师表示，这项试验数据并不支持研究者的正面结论；当他被问到有关使用节律性化学疗法在进展性癌症病患的意见时，他向Medscape表示，这项试验结果并不显著，问题在於许多病患不想接受化学疗法，所以这项使用低剂量、持续使用的策略希望可以用在这些病患身上；但不幸的，这项试验的数据并不支持这样的做法是有效的。

For Clark Haskins, MD, from New Mexico Oncology Hematology Consultants, Ltd, New Mexico Cancer Center, the data do not support the researchers' positive conclusions."The results were crummy," he told Medscape when asked what he thought of the strategy of using metronomic chemotherapy in advanced disease."The problem is that there are a lot of patients who don't want to take chemotherapy, so this strategy is trying to reach these patients," he said."Unfortunately, the data don't support that the strategy works."

新墨西哥癌症中心新墨西哥肿瘤血液肿瘤咨询家Clark Haskins医师表示，这项试验数据并不支持研究者的正面结论；当他被问到有关使用节律性化学疗法在进展性癌症病患的意见时，他向Medscape表示，这项试验结果并不显著，问题在于许多病患不想接受化学疗法，所以这项使用低剂量、持续使用的策略希望可以用在这些病患身上；但不幸的，这项试验的数据并不支持这样的做法是有效的。

Despite the poor response rates in the chemotherapy-alone group, Dr. Burstein believes that metronomic chemotherapy combined with bevacizumab should be investigated further, given the tolerability of the agents and the preclinical rationale for efficacy. When asked why cyclophosphamide and methotrexate were selected for metronomic chemotherapy, he observed that many patients in this setting are already somewhat chemotherapy-resistant.

尽管只接受化学疗法的病患反应率很低，Burstein医师相信节律性化学疗法加上bevacizumab应该进一步研究，因为该药物的耐受性良好，而且临床前实验认为是有效的；当被问到为什么选择cyclophosphamide与methotrexate作为节律性化学疗法的药物，他观察发现，许多病患在这个时候已经对许多化学疗法产生抗药性。

Despite the poor response rates in the chemotherapy-alone group, Dr. Burstein believes that metronomic chemotherapy combined with bevacizumab should be investigated further, given the tolerability of the agents and the preclinical rationale for efficacy. When asked why cyclophosphamide and methotrexate were selected for metronomic chemotherapy, he observed that many patients in this setting are already somewhat chemotherapy-resistant.

尽管只接受化学疗法的病患反应率很低，Burstein医师相信节律性化学疗法加上bevacizumab应该进一步研究，因为该药物的耐受性良好，而且临床前实验认为是有效的；当被问到为什麼选择cyclophosphamide与methotrexate作为节律性化学疗法的药物，他观察发现，许多病患在这个时候已经对许多化学疗法产生抗药性。

The exemplary anti-cancer compositions of the present invention may also be used as adjuncts with one or more of the following: a surgical procedure, a laser therapy, a micro-radiation pellet implant, a cryogenic procedure, a chemotherapy, a radiation therapy, a electrodessication/curettage, a laetrile therapy, an immuno-therapy, and an enzyme therapy.

本发明技术抗癌制剂独特之处还在于可以与下列之一或多者结合使用：手术治疗、激光疗法、微放射颗粒植入、冷冻疗法、化学疗法、放射疗法、电烧法/刮除术、苦杏仁苷、免疫疗法和酶替代疗法。

According to the clear water experiment, aeration performance of the new equipment is good with high total oxygen transfer coefficient and oxygen utilization ratio.

曝气设备的动力效率在叶轮转速为120rpm～150rpm时取得最大值，此时氧利用率和充氧能力也具有较高值。

The environmental stability of that world - including its crushing pressures and icy darkness - means that some of its most famous inhabitants have survived for eons as evolutionary throwbacks, their bodies undergoing little change.

稳定的海底环境─包括能把人压扁的压力和冰冷的黑暗─意谓海底某些最知名的栖居生物已以演化返祖的样态活了万世，形体几无变化。